CO5251401A1 - Inhibidores de fab i - Google Patents

Inhibidores de fab i

Info

Publication number
CO5251401A1
CO5251401A1 CO00076101A CO00076101A CO5251401A1 CO 5251401 A1 CO5251401 A1 CO 5251401A1 CO 00076101 A CO00076101 A CO 00076101A CO 00076101 A CO00076101 A CO 00076101A CO 5251401 A1 CO5251401 A1 CO 5251401A1
Authority
CO
Colombia
Prior art keywords
4alkyl
het
fab
inhibitors
6alkyl
Prior art date
Application number
CO00076101A
Other languages
English (en)
Spanish (es)
Inventor
William H Miller
Kenneth A Newlander
Mark A Seefeld
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of CO5251401A1 publication Critical patent/CO5251401A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Semiconductor Lasers (AREA)
CO00076101A 1999-10-08 2000-10-06 Inhibidores de fab i CO5251401A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15852999P 1999-10-08 1999-10-08

Publications (1)

Publication Number Publication Date
CO5251401A1 true CO5251401A1 (es) 2003-02-28

Family

ID=22568552

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00076101A CO5251401A1 (es) 1999-10-08 2000-10-06 Inhibidores de fab i

Country Status (8)

Country Link
EP (1) EP1225895B1 (https=)
JP (1) JP4961084B2 (https=)
AT (1) ATE294578T1 (https=)
AU (1) AU1192501A (https=)
CO (1) CO5251401A1 (https=)
DE (1) DE60019954T2 (https=)
HK (1) HK1049610A1 (https=)
WO (1) WO2001026654A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5180550A1 (es) 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibidores de fab i
CO5370679A1 (es) 1999-06-01 2004-02-27 Smithkline Beecham Corp Inhibidores fab 1
US6762201B1 (en) 1999-10-08 2004-07-13 Affinium Pharmaceuticals, Inc. Fab I inhibitors
US6730684B1 (en) * 1999-10-08 2004-05-04 Affinium Pharmaceuticals, Inc. Fab I inhibitors
CO5251397A1 (es) * 1999-10-08 2003-02-28 Smithkline Beecham Corp Inhibidores de fab i
ATE285821T1 (de) 1999-10-08 2005-01-15 Affinium Pharm Inc Fab i inhibitoren
KR20030060904A (ko) * 2000-10-06 2003-07-16 뉴로젠 코포레이션 Ｃｒｆ 수용체 조절자로서 벤즈이미다졸 및 인돌 유도체
CA2444597A1 (en) 2001-04-06 2002-10-06 Affinium Pharmaceuticals, Inc. Fab i inhibitors
EP1575951B1 (en) * 2002-12-06 2014-06-25 Debiopharm International SA Heterocyclic compounds, methods of making them and their use in therapy
DE602004016831D1 (de) * 2003-03-17 2008-11-13 Affinium Pharm Inc Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
CN101203504B (zh) * 2005-05-03 2012-11-14 兰贝克赛实验室有限公司 抗微生物剂
DK1879877T3 (da) 2005-05-03 2013-04-15 Ranbaxy Lab Ltd Antimikrobielle midler
JP2009533315A (ja) * 2006-04-10 2009-09-17 ランバクシー ラボラトリーズ リミテッド 抗菌剤
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
EP2742047B1 (en) 2011-08-10 2021-05-12 Janssen Sciences Ireland Unlimited Company Antibacterial piperidinyl substituted 3,4-dihydro-1h-[1,8]naphthyridinones
US9394295B2 (en) 2011-08-10 2016-07-19 Janssen Sciences Ireland Uc Antibacterial homopiperidinyl substituted 3,4-dihydro-1H-[1,8]naphthyridinones
JO3611B1 (ar) 2011-08-10 2020-08-27 Janssen Sciences Ireland Uc سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
SI2861608T1 (sl) 2012-06-19 2019-08-30 Debiopharm International Sa Derivati predzdravila (E)-N-metil-N-((3-metilbenzofuran-2-IL)metil)- 3-(7-okso-5,6,7,8-tetrahidro-1 ,8-nafthiridin-3-il)akrilamid
CN104981466B (zh) 2012-08-10 2019-06-14 爱尔兰詹森科学公司 抗细菌化合物
MX363480B (es) 2012-08-10 2019-03-22 Janssen Sciences Ireland Uc Compuestos bacterianos que constan de un grupo heterocicloalquilo basado en nitrógeno que contiene un doble enlace unido a carbonilo que inhiben la enzima fabi.
BR122023021456A2 (pt) 2016-02-26 2024-02-20 Debiopharm International S.A. Uso de di-hidrogeno fosfato de {6- [(e)-3-{metil[(3-metil-1-benfofuran-2- iol)metil]amino)-3- oxopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)- il}metila para tratamento de osteomielite do pé diabético e composição farmacêutica
LT3923914T (lt) 2019-02-14 2023-07-25 Debiopharm International S.A. Afabicino kompozicija, jos gamybos būdas
CN113939306B (zh) 2019-06-14 2024-07-19 德彪药业国际股份公司 用于治疗涉及生物膜的细菌感染的药物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207679B1 (en) * 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US5932743A (en) * 1997-08-21 1999-08-03 American Home Products Corporation Methods for the solid phase synthesis of substituted indole compounds

Also Published As

Publication number Publication date
HK1049610A1 (zh) 2003-05-23
DE60019954D1 (en) 2005-06-09
WO2001026654A1 (en) 2001-04-19
JP2003511415A (ja) 2003-03-25
DE60019954T2 (de) 2006-02-23
EP1225895A1 (en) 2002-07-31
ATE294578T1 (de) 2005-05-15
JP4961084B2 (ja) 2012-06-27
EP1225895B1 (en) 2005-05-04
AU1192501A (en) 2001-04-23
EP1225895A4 (en) 2002-11-13

Similar Documents

Publication Publication Date Title
CO5251401A1 (es) Inhibidores de fab i
DE60029235D1 (en) Fab-i-hemmer
TR200103485T2 (tr) Antibakteriyel bileşikler.
WO2001022953A3 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
GB0005251D0 (en) Therapeutic compounds
AU2560300A (en) Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsins
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
MXPA04001889A (es) Inhibidores de la alquin-aril fosfodiesterasa-4.
ZA200101821B (en) Use of heteroaryl substituted n-(indole-2-carbonyl-) amides for treatment of infection.
NO996108L (no) 9-oksinerytromycinderivater
SE0101932D0 (sv) Pharmaceutical combinations
NO20022470D0 (no) Pyrimidinderivater
WO2003053971A8 (en) Pyridoquinoxaline antivirals
WO2002016312A3 (de) NEUE VERBINDUNGEN, DIE FAKTOR Xa-AKTIVITÄT INHIBIEREN
EE200400043A (et) Uudsed heterotsüklilised ühendid kui selektiivsedbakteriaalsed DHFR inhibiitorid ning nende kasutamine
WO2003049690A3 (en) Hiv integrase inhibitors
DE60111774D1 (de) Antibakterielle verbindungen
UA88773C2 (ru) Способ лечения раздражения мочевого пузыря и чрезмерно активного мочевого пузыря
WO2001081316A3 (en) Substituted phenyl farnesyltransferase inhibitors
IL162689A0 (en) Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
SE0104326D0 (sv) Therapeutic heterocycles
WO2003049688A3 (en) Bis hydrochloride monohydrate salt of rsv fusion inhibitor
NO20033634L (no) GLyT-1-inhibitorer
EP1439185A4 (en) STABILIZATION OF AMRUBICIN HYDROCHLORIDE
WO2003039231A3 (en) Compounds and methods for treating transplant rejection

Legal Events

Date Code Title Description
FA Application withdrawn